HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b. - Wikidata - awgldk - TriplyDB

HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.

HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.

http://www.wikidata.org/entity/Q37255017

about

Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.

P2860

Q45326295-93BF0278-6171-419F-B292-1DF48587374A

P2860

HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.

http://www.wikidata.org/entity/Q37255017

description

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

name

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@en

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@nl

type

label

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@en

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@nl

prefLabel

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@en

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@nl

P1433

Q37255017-37D671CD-547C-4700-A65A-B1D89D933644

P1476

Q37255017-0D2B15AC-69D7-43B3-AF82-433A83067E95

P2093

Q37255017-5640F72F-5071-4557-BDE1-CE24AEF1F0AB

Q37255017-7E936806-E2CD-427F-800F-FFE09E9848F7

Q37255017-854F6004-7DC4-4927-8229-CC35C6986D53

Q37255017-8D0CD3AD-9934-458D-8840-7CE8D9D90039

Q37255017-8D3F2A11-48D5-4743-940E-5515D04A8498

P2860

Q37255017-1455B509-75D0-4D7E-A506-6A3A2200067F

Q37255017-1CAF414D-C974-4125-8DE0-8C9102F12D35

Q37255017-2923F0EC-694C-4A15-81DD-FFF36FE266A8

Q37255017-3070C760-2A85-43C3-B875-CA0D9934674D

Q37255017-3FF0E705-E70B-4C1E-90C1-D3FEC9CAA9CF

Q37255017-4D52F96C-8BAA-40AE-9598-F30E216F6522

Q37255017-60EA0E38-93BD-488F-96D0-5F500EFE4091

Q37255017-8F55734E-3954-426E-9DAB-D1B0A6B7CCB6

Q37255017-ABBA67A7-E49B-414C-9060-EEF888F812AC

Q37255017-ADD9FFDA-6ED7-4DD8-ABC5-DB058F01AAFE

P304

Q37255017-C51FB065-7544-4E41-9DA2-34935F7C5B19

P31

Q37255017-79F9ABF6-9D5F-4610-ADE8-D63E327417FC

P356

Q37255017-66D221D4-FB2C-4CC1-A899-CE8E2DBB22EA

P407

Q37255017-12666561-D6FB-49F8-A904-5021FEFB892B

P433

Q37255017-1D94D1CF-698C-41B4-AE25-5837EE0D5C78

P478

Q37255017-7AD6D191-67F8-4D02-95B7-B27B342E5475

P577

Q37255017-D7EDD8E1-9012-453C-AC29-E408148D9E18

P698

Q37255017-EF53844D-D6F0-4D6C-8CF4-B7F92F6F332B

P921

Q37255017-BA64DC83-9C62-4C11-A15A-E957F31827C4

P932

Q37255017-4F376D05-8C01-41D8-B677-FFD085FD1FBF

P356

0366-6999.189904

P1433

Chinese Medical Journal

P1476

HBcrAg Identifies Patients Fai ...... Pegylated Interferon Alfa-2b.

@en

P2093

Hui Ma

http://www.w3.org/2001/XMLSchema#string

Lai Wei

http://www.w3.org/2001/XMLSchema#string

Qian Jin

http://www.w3.org/2001/XMLSchema#string

Rui-Feng Yang

http://www.w3.org/2001/XMLSchema#string

Xiao-He Li

http://www.w3.org/2001/XMLSchema#string

P2860

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain.

Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.

Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.

Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B.

Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.

Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.

P304

2212-2219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0366-6999.189904

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27625094

http://www.w3.org/2001/XMLSchema#string

P921

P932

5022343

http://www.w3.org/2001/XMLSchema#string